Role of Spectrin Mutations in Spinocerebellar Ataxia Type 5 (SCA5)
A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY
Damaris Nadia Lorenzo Vila
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY
ADVISOR: Laura P. W. Ranum, Ph.D.
August, 2009
© DAMARIS NADIA LORENZO VILA, 2009
AKNOWLEDGEMENTS
I will take this opportunity to recognize a group of people who has been instrumental during my years as a Graduate Student. Specially, I would like to thank my advisor, Dr. Laura P. W. Ranum, for her encouragement and support. I am very grateful to Laura for her faith in me and my work, and for providing me with the tools and guidance to become an independent scientist. I also would like to thank all past and present members of the Ranum lab for both professional and personal relationships. They are extremely cooperative, friendly, and fun to work with. I am specially thankful to
Karen Armbrust and Katie Dick for providing the human β-III spectrin clones and for many useful discussions about SCA5. I want to thank Marcy Weatherspoon for her help with the SSCP screen and Sarah Kreykes for her help collecting DNA samples and clinical information from ataxia families.
I am indebted to Dr. Tom Hays for all his enthusiasm and guidance with the fly project and to all the members of the Hays lab for sharing their expertise, time, and resources with me. In particular, I am greatly thankful to Sarah Mische for her help with the initial characterization of the SCA5 flies and Yungui He for his help with cell culture and anything else I needed in the lab. I extend my most special gratitud to Mingang Li for his friendship, for teaching me a great deal of fly genetics, and for his constant help in the fly room and through each experiment.
ILastly, wantto thank myhusband Ismaelandmyson Edgar for theirunlimitedloveand dedication andmy dad, sister,family, and friends for their continuous encouragement. i ABSTRACT
Spinocerebellar ataxia type 5 (SCA5) is a dominant neurodegenerative disorder
caused by mutations in the SPBTN2 gene encoding the cytoskeletal protein β-III spectrin.
To get insight into the biology of the disease and the normal function of β-III spectrin, and to estimate the frequency of SCA5 mutations among ataxia patients, I used a forward human genetic approach to identify novel SPTBN2 mutations. Screening of the SPTBN2 gene in a cohort of families with dominant ataxia of unknown etiology and a large group of ataxia samples identified seventeen novel variants not found in the general population.
Putative mutations were identified in the areas comprising the second calponin homology domain, spectrin repeat two to four, and the ninth spectrin repeat of β-III spectrin. To investigate the downstream effects of the American and German SCA5 mutations in neurons, I established a series of transgenic Drosophila models that express human β-III- spectrin or fly β-spectrin proteins containing SCA5 mutations. Through genetic and functional analyses I show that expression of mutant spectrin in the eye causes a progressive neurodegenerative phenotype and expression in larval neurons results in posterior paralysis, reduced synaptic terminal growth, and axonal transport deficits.
These phenotypes are genetically enhanced by both dynein and dynactin loss-of-function mutations. I have additionally used the SCA5 fly models to conduct modifier screens and identify genes and biological pathways that may contribute to SCA5 pathogenesis. These studies revealed genetic interactors implicated in a wide range of biological functions including intracellular transport, synapse formation and function, protein homeostasis, and transcription regulation.
ii TABLE OF CONTENTS
Acknowledgements______i
Abstract ______ii
Table of Contents ______iii
List of Figures ______v
List of Tables ______vii
Abbreviations ______viii
Chapter 1: Introduction to the spinocerebellar ataxias and SCA5
I. The spinocerebellar ataxias ______1
II. Spinocerebellar ataxia type 5 ______4
A. Genetics of SCA5 ______4
B. Clinical, anatomical, and neuropathological features of SCA5 ____ 6
III. The spectrin cytoskeleton ______7
A. Structural components ______7
B. Functions ______9
IV. Introduction to human β-III spectrin ______12
A. Expression pattern and functional domains______12
B. Proposed functional roles______13
V. Conclusions ______15
VI. Overall Aims and Hypotheses ______16
Chapter 2: Identification of novel SCA5 mutations
I. Introduction ______25
iii II. Results ______27
III. Discussion ______33
Chapter 3: Establishment and characterization of transgenic SCA5 models in Drosophila
I. Introduction ______44
II. Results ______46
III. Discussion ______54
Chapter 4: Genetic screen for modifiers of SCA5-induced neurodegeneration in
Drosophila
I. Introduction ______80
II. Results ______82
III. Discussion ______88
Chapter 5: Conclusions and Future Directions
I. Future Directions ______102
Chapter 6: Materials and Methods
I. Identification of novel SCA5 mutations______106
II. Drosophila SCA5 models ______108
III. SCA5 modifier screen______117
References ______121
iv LIST OF FIGURES
Chapter 1
Figure 1- SCA5 mutations ______17
Figure 2- Cerebellar atrophy in SCA5 ______18
Figure 3- ß-III spectrin expression in control and American SCA5 cerebellar tissue 19
Figure 4- The spectrin tetramer ______20
Figure 5- Functions of human β-III spectrin ______22
Chapter 2
Figure 6- Summary of mutations in the SPTBN2 gene ______37
Figure 7- Novel mutations in the ninth spectrin repeat of β-III spectrin ______38
Figure 8- Evolutionary conservation of novel SPTBN2 mutations ______39
Chapter 3
Figure 9- Homology between human β-III spectrin and Drosophila β-spectrin ____ 60
Figure 10- Constructs generated to express human β-III spectrin in flies ______61
Figure 11- Eye phenotype of flies expressing mutant β-III spectrin ______62
Figure 12- Mutant β-III spectrin causes a progressive eye phenotype ______64
Figure 13- β-III spectrin incorporates into α/β spectrin complexes in Drosophila __ 65
Figure 14- Constructs generated to overexpress endogenous fly β-spectrin ______66
Figure 15- Human β-III spectrin and fly β-spectrin share functional pathways _____ 67
Figure 16- Spectrin mutations affects synaptic terminal size at the NMJ ______68
Figure 17- Spectrin mutations cause larval posterior paralysis ______70
Figure 18- Spectrin mutations cause accumulation of synaptic proteins ______71
Figure 19- Spectrin mutations disrupt vesicle transport ______73
v Figure 20- Genetic interaction between spectrin and dynein pathways ______74
Chapter 4
Figure 21- Third chromosome deficiencies modify the SCA5 eye phenotype ______92
Figure 22- Genomic region containing putative SCA5 interactors ______93
Figure 23- P-element screen identifies SCA5 genetic interactors ______94
Figure 24- Functional activities of modifiers of SCA5 neurodegeneration ______95
vi LIST OF TABLES
Chapter 1
Table 1- Summary of SCAs classification______23
Table 2- Clinical features of SCA5 ______24
Chapter 2
Table 3- Summary of novel mutations in the SPTBN2 gene ______41
Table 4- Families with novel SPTBN2 mutations identified by SSCP analysis _____ 42
Table 5- Summary of novel SNPs in SPTBN2 ______43
Chapter 3
Table 6- Analysis of synaptotagmin-GFP vesicles motions in segmental nerves ___ 77
Table 7- Analysis of synaptobrevin-GFP vesicles motions in segmental nerves ____ 78
Chapter 4
Table 8- Third chromosome deficiencies modify the SCA5 eye phenotype ______96
Table 9- Secondary screen defines regions containing genetic interactors ______97
Table 10- Activities of genetic modifiers of SCA5 neurodegeneration ______98
Table 11- Lethal phase analysis for SCA5genetic interactors ______101
Chapter 6
Table 12- Primer sequences and PCR conditions for mutation screening______119
vii ABREVIATIONS
ADCA ______autosomal dominant cerebellar ataxia
ARP1 ______actin related protein 1
ABD ______actin binding domain
BAC ______bacterial artificial chromosome
bp, kb, Mb ______basepairs, kilobases, megabases
BSA ______bovine serum albumin
°C ______temperature in degrees Celsius
CEPH ______Centre d'Etude du Polymorphisme Humain
CH domain ______calponin homology domain
CS ______conservation score
CSP ______cysteine string protein
Da, kDa ______daltons, kilodaltons
Df ______deficiency
DNA, cDNA ______deoxyribonucleic acid, coding DNA
EAAT4 ______excitatory amino acid transporter 4
ECL ______enhanced chemiluminescence
elav ______embryonic lethal, abnormal vision
FITC ______fluorescein isothiocyanate
GO ______gene ontology
gmr ______glass multiple reporter
GluR δ2______glutamate receptor delta 2 subunit
HEK 293 ______human embryonic kidney cell lines
viii IgA ______immunoglobulin A
IP ______immunoprecipitation
mGluR1 α______metabotropic glutamate receptor 1 alpha
MRI ______magnetic resonance imaging
MT______microtubules
NMJ______neuromuscular junction